, Cancer Incidence and Mortality World, 2008.
The global epidemiology of hepatocellular carcinoma: present and future, Clinical Liver Disease, vol.15, pp.223-266, 2011. ,
Non-viral causes of hepatocellular carcinoma, World Journal of Gastroenterology, vol.16, pp.3603-3618, 2010. ,
Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review, Currents Genomics, vol.12, pp.130-137, 2011. ,
Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma, J Gastroenterol Hepatol, vol.23, pp.110-128, 2008. ,
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Natural Genetics, vol.44, pp.694-702, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00719917
Wnt/beta-catenin signaling: new (and old) players and new insights, Current Opinion in Cell Biology, vol.20, pp.119-144, 2008. ,
Wnt/beta-catenin signaling in development and disease, Cell, vol.127, pp.469-80, 2006. ,
Regulation of cadherin-mediated adhesion in morphogenesis, Natural Reviews Molecular Cell Biology, vol.6, pp.622-656, 2005. ,
Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes, Cell, vol.143, pp.1136-1184, 2010. ,
Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction, J Cell Biol, vol.180, pp.1087-100, 2008. ,
Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma, Can Res J, vol.67, issue.22, pp.10831-10840, 2007. ,
Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites, J Biologic Chem, vol.278, pp.31781-31790, 2003. ,
Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma, Molecular Cancer, vol.7, p.21, 2008. ,
GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma, Cancer Letter, vol.199, pp.201-209, 2003. ,
WNT/beta-catenin signaling in liver health and disease, Hepatology, vol.45, pp.1298-305, 2007. ,
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas, Oncogene, vol.26, pp.774-80, 2007. ,
Genetics and epigenetics of liver cancer, Natural Biotechnology, vol.30, pp.381-385, 2013. ,
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia. Hepatitis Research and Treatment, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00855692
Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases, Cancer Letter, vol.264, pp.201-209, 2008. ,
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection, Proceedings of the Nationall Academy of Science USA, vol.98, pp.31-37, 2001. ,
WNT/beta-catenin signaling in liver health and disease, Hepatology, vol.45, issue.5, pp.1298-305, 2007. ,
Role of Wnt/ -catenin signaling in liver metabolism and cancer, The International Journal of Biochemistry & Cell Biology, vol.43, pp.1021-1030, 2011. ,
Mutational spectrum of betacatenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas, Oncogene, vol.21, pp.4863-71, 2002. ,
Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: a case report, Genes Chromosomes Cancer, vol.45, pp.1050-1057, 2006. ,
Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas, International Journal Oncology, vol.12, pp.443-450, 1998. ,
Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter, Gastroenterology, vol.135, pp.2128-2168, 2008. ,
Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma, J Gastroenterol Hepatol, vol.23, pp.110-118, 2008. ,
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma, Gastroenterology, vol.127, pp.1110-1132, 2004. ,
Somatic changes in primary liver cancer in Russia: a pilot study, Mutation Research, vol.755, pp.90-99, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02863297
Regulation of beta-catenin structure and activity by tyrosine phosphorylation, J Biol Chem, vol.276, pp.20436-20479, 2001. ,
Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma, Chinese Medical Journal (Engl), vol.116, pp.1885-92, 2003. ,
Betacatenin mutations are associated with a subset of lowstage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis, Am J Pathol, vol.157, pp.763-70, 2000. ,
Expression of beta-catenin in hepatocellular carcinoma, World Journal Gastroenterology, vol.11, pp.2398-401, 2005. ,
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections, Genomics, vol.102, pp.74-83, 2013. ,
Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China, Mutation Research, vol.641, pp.27-35, 2008. ,
Beta-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance, Cancer, vol.92, pp.136-181, 2001. ,
CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1, Molecular Carcinogenesis, vol.31, pp.68-73, 2001. ,
Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis, Liver International, vol.25, pp.70-76, 2005. ,
Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia. Hepatology Research Treatment, 2011. ,
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis, Gastroenterology, vol.120, pp.1763-73, 2001. ,
Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas, International Journal Oncology, vol.24, pp.1077-83, 2004. ,
Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis, International Journal of Cancer, vol.106, pp.334-375, 2003. ,
Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection, Am J Pathol, vol.155, pp.1795-1801, 1999. ,
Enhancement of canonical Wnt/ -catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells, PLoS One, vol.6, p.27496, 2011. ,
Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling, Hepatology, vol.56, pp.1631-1671, 2012. ,
Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma, J Gastroenterol, vol.43, pp.378-89, 2008. ,
Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway, International Journal of Cancer, vol.135, pp.635-681, 2014. ,
Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/ -catenin signaling, Cancer Letter, vol.300, pp.162-72, 2011. ,
Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation, Cancer Letter, vol.343, pp.90-97, 2014. ,